Search results
ANALYSIS: ATA’s Chris Spear earns $1.9M, but where are his results?
FreightWaves via Yahoo Finance· 3 days agoBased on its results this Congress, the American Trucking Associations’ lobbying efforts make it...
Best Financial-Planning Advice for LGBTQ Couples
Barrons.com· 3 days agoEven if you live in a fairly progressive state like California, the process is laborious and it’s expensive. It can cost $200,000 to $300,000....
Arcata City Council -- Wednesday @ 5:15 p.m.
Lost Coast Outpost· 15 hours agoArcata City Council June 12, 2024, 5:15 p.m. 1. CALL TO ORDER A. Roll Call 2. PUBLIC COMMENT
Biden Shoots Down Measure Limiting SEC Crypto Authority
PYMNTS.com· 6 days agoPresident Joe Biden has vetoed a resolution limiting the Securities and Exchange Commission’s (SEC)...
FDA advisers vote against first MDMA therapy to treat PTSD
CNN.com· 3 days agoA federal advisory committee on Tuesday voted overwhelmingly against of the use of MDMA, commonly...
Psychoactive drugs are having a moment: The FDA will soon weigh in
Medical Xpress· 5 days agoLori Tipton is among the growing number of people who say that MDMA, also known as ecstasy, saved...
Northrop Grumman price target cut to $500 by Jefferies By Investing.com
Investing.com· 2 days agoThis adjustment comes following a visit to Northrop's facilities in Palmdale, California, where the...
AAMVA Leader Ian Grossman Talks Digital IDs, Embracing Mobile Wallets In Interview
Forbes· 2 days agoIndeed, as a longtime fan of Apple products, the advent of Apple Wallet (née Passbook) and particularly Apple Pay has been one of my favorite advancements of mobile technology in the last decade ...
EVs Are Cleaner And Have Brighter Futures Than Traditional Cars
Forbes· 6 days agoThe 2024 national elections will pit fossil-fueled interests against the clean energy economy. To that end, electric vehicles will take center stage. The technology has come a long way over ...
Psychoactive drugs are having a moment. The FDA will soon weigh in
The State· 5 days agoPsychoactive drugs are having a moment. Investors are piling into the nascent field, and a host of medications based on MDMA, LSD, psychedelic mushrooms, ketamine, the South American plant mixture ...